secwatch / observer
8-K filed May 2, 2023, 7:59 PM ET ticker CRVW CIK 0001377149
debt confidence low sentiment negative materiality 0.60

CareView Communications enters 30th amendment to credit modification agreement

CareView Communications Inc

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.7

CareView Communications Inc amended Thirtieth Amendment to Modification Agreement with PDL Investment Holdings, LLC valued at Amendment to credit agreement modification terms (effective 2023-05-02).

Action
amendment
Agreement
credit facility
Counterparty
PDL Investment Holdings, LLC
Value
Amendment to credit agreement modification terms
Effective
2023-05-02
Exact text from the filing
Thirtieth Amendment to Modification Agreement Modification Agreement to Credit Agreement As previously reported by CareView Communications, Inc. (the "Company") in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on February 5, 2018, the Company, CareView Communications, Inc., a Texas corporation and a wholly owned subsidiary of the Company (the "Borrower"), CareView Operations, L.L.C., a Texas limited liability company and a wholly owned subsidiary of the Borrower (the "Subsidiary Guarantor"), and PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender (the "Lender") under the Credit Agreement (the "Credit Agreement") dated as of June 26, 2015, as amended, by and among the Company, the Borrower and the Lender, entered into a Modification Agreement on February 2, 2018, effective as of December 28, 2017 (the "Modification Agreement"), with respect to the Credit Agreement in order to
View on SEC.gov

Browse all material agreements →

CareView Communications Inc filing history →

Source: SEC EDGAR
accession 0001387131-23-005906
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.